Speakers: Angie Lewis-White, Myovant Sciences; Eileen Ring, Alladapt Immunotherapeutics Inc.; Renard Jackson, Frontida BioPharm, Inc.; Lewis Stuart, CymaBay Therapeutics, Inc.; Kurt Mayrand, ChemoCentrys; John Farris, Graphite Bio
Organizers: Minli Xie, Erasca Inc.; Angie Lewis-White, Myovant Sciences
Date: 2023-02-08- 02/09/2023
Time: 8:30-12:30 Pacific Time
Registration fee: Free
Location: Online via zoom
Major Sponsor:
Vendor show vendors registered to date:
Registration: http://www.PBSS.org
Registration deadline:2023-02-04  (it will close sooner if the seating cap is reached)

About the Topic

After years of hard work in research and development of a new drug, what does it take for a small entrepreneur company to successfully launch a new product in this highly competitive and highly regulated environment.  Drug launch requires a cross-functional planning, coordination and implementation, and this workshop will describe the key areas and activities go into preparation and execute a launch including some case studies.  Often, decisions made early during development would impact launch preparations. The goal of this workshop is to provide some fundamentals on:

1) an overview to key elements for a new product launch including considerations during early research & development
2) creating a commercial plan through market research, brand establishment and building a sales force
3) important role of market access and process of establishing market access
4) meeting the compliance requirements in both quality and regulatory aspects 
5) understanding on importance of a robust commercial supply chain in today’s world
6) what is involved with serialization and third-party logistics

Note: This is an online meeting, The Zoom link will be sent to the registrants 1+ days before the event.

The speakers are experienced leaders in the Pharma/Biotech industry who have taken multiple products to market successfully.  They will share their experiences and bring these fundamentals to life through examples.

Session 1 (Feb. 8, 2023)

Session 2 (Feb. 9, 2023)